Metraipolis › archive › dc_2daec245d8d7

Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals — Europe PMC PMID:35679259

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35679259
DOI
10.1371/journal.pone.0264298
License (as archived)
CC0-1.0
Archived
2026-10-18T08:25:17.249Z
SHA-256 of the archived text
fa18b06ad0022e7d35451a261256913195001e15eef0778724ffe6815b16799d
Stable URL of this page
https://metraipolis.com/documento/dc_2daec245d8d7

How to cite

Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals — Europe PMC PMID:35679259 — Europe PMC (en), https://europepmc.org/article/MED/35679259 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2daec245d8d7 (Metraipolis archive dc_2daec245d8d7, sha256 fa18b06ad0022e7d35451a261256913195001e15eef0778724ffe6815b16799d)
BibTeX
@misc{dc2daec245d8d7,
  title = {Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals — Europe PMC PMID:35679259},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35679259},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2daec245d8d7; sha256 fa18b06ad0022e7d35451a261256913195001e15eef0778724ffe6815b16799d},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35679259. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The association between COVID-19 symptoms and antibody responses against SARS-CoV-2 is poorly characterized. We analyzed antibody levels in individuals with known SARS-CoV-2 infection to identify potential antibody-symptom associations. Convalescent plasma from 216 SARS-CoV-2 RNA+ individuals with symptomatology information were tested for the presence of IgG to the spike S1 subunit (Euroimmun ELISA), IgG to receptor binding domain (RBD, CoronaCHEK rapid test), and for IgG, IgA, and IgM to nucleocapsid (N, Bio-Rad ELISA). Logistic regression was used to estimate the odds of having a COVID-19 symptom from the antibody response, adjusting for sex and age. Cough strongly associated with antibodies against S1 (adjusted odds ratio [aOR] = 5.33; 95% CI from 1.51 to 18.86) and RBD (aOR = 4.36; CI 1.49, 12.78). In contrast, sore throat significantly associated with the absence of antibodies to S1 and N (aOR = 0.25; CI 0.08, 0.80 and aOR = 0.31; 0.11, 0.91). Similarly, lack of symptoms associated with the absence of antibodies to N and RBD (aOR = 0.16; CI 0.03, 0.97 and aOR = 0.16; CI 0.03, 1.01). Cough appeared to be correlated with a seropositive result, suggesting that SARS-CoV-2 infected individuals exhibiting lower respiratory symptoms generate a robust antibody response. Conversely, those without symptoms or limited to a sore throat while infected with SARS-CoV-2 were likely to lack a detectable antibody response. These findings strongly support the notion that severity of infection correlates with robust antibody response.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-06-09).
Identificativi: PMID 35679259 · PMCID PMC9182712 · DOI 10.1371/journal.pone.0264298.
Descrittori MeSH principali: Pharyngitis; COVID-19.
Pagina: https://europepmc.org/article/MED/35679259 — https://doi.org/10.1371/journal.pone.0264298. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-18T08:17:46.775Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.